An interventional study of Kinesio® tape application and Placebo in Kinesio Taping and Muscle Oxygenation, sponsored by Okan University. Not yet recruiting. Open to male participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-07.
Sponsored by Okan University · Not applicable, Interventional, and Prevention
The aim of this study is to investigate the effects of kinesio taping applied to the gastrocnemius muscle on muscle oxygenation, pain pressure threshold, and mechanical properties of the muscle in healthy young individuals.
Individuals meeting the inclusion criteria will be randomly assigned to two groups using block randomization: the Kinesio® tape group (KTG) and the placebo group (PG). Following assessments, individuals will be assigned to their respective groups and will receive Kinesio® tape application from a physiotherapist. Assessments will be repeated for all individuals at 1 hour and 36 hours after application.
Okan University is the lead sponsor of 97 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
KT will be applied by a certified physiotherapist following standardized procedures. The skin of the lower leg will be cleaned with alcohol before application. Participants will be positioned prone with their lower extremities fully extended, knees in full extension, and ankles in a neutral position. The tape will be placed along the gastrocnemius muscle, over the calcaneal fat pad, to the distal femur. Tension in the KT group will be between 15-25%, with active stretching of the gastrocnemius muscle by the individual during taping.
Other: Kinesio® tape application
The skin of the lower leg will be cleaned with alcohol before the procedure. Participants will be positioned prone with their lower extremities fully extended, knees in full extension, and ankles in a neutral position. The band will be placed along the gastrocnemius muscle, over the calcaneal fat pad, to the distal femur. Tension will be achieved by leaving the band unstretched.
Other: Placebo
KT will be applied by a certified physiotherapist following standardized procedures. The skin of the lower leg will be cleaned with alcohol before application. Participants will be positioned prone with their lower extremities fully extended, knees in full extension, and ankles in a neutral position. The tape will be placed along the gastrocnemius muscle, over the calcaneal fat pad, to the distal femur. Tension in the KT group will be between 15-25%, with active stretching of the gastrocnemius muscle by the individual during taping.
The skin of the lower leg will be cleaned with alcohol before the procedure. Participants will be positioned prone with their lower extremities fully extended, knees in full extension, and ankles in a neutral position. The band will be placed along the gastrocnemius muscle, over the calcaneal fat pad, to the distal femur. Tension will be achieved by leaving the band unstretched.
Oxygenation Analysis of the Gastrocnemius Muscle
Time frame: Before the application, at the 1st hour and at the 36th hour of the application
Pain Pressure Threshold
Time frame: Before the application, at the 1st hour and at the 36th hour of the application
Analysis of the Mechanical Properties of the Gastrocnemius Muscle
Time frame: Before the application, at the 1st hour and at the 36th hour of the application
No study locations are listed for this record.
Start is estimated for May 2026; primary completion for Jun 2026, 1 month later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Okan University